Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Mahdavi, Mohammad  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
1
Ghomi MKhalili, Noori M, Montazer MNazari, Zomorodian K, Dastyafteh N, Yazdanpanah S, Sayahi MHosein, Javanshir S, Nouri A, Asadi M, et al. [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studies. Sci Rep. 2023;13(1):10136.
A
Asadipour A, Pourshojaei Y, Mansouri M, Mahdavizadeh E, Irajie C, Mottaghipisheh J, Faghih-Mirzaei E, Mahdavi M, Iraji A. Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer's disease management; in vitro and in silico study. BMC Chem. 2024;18(1):70.
D
Niri DRezapour, Sayahi MHosein, Behrouz S, Moazzam A, Rasekh F, Tanideh N, Irajie C, Nezhad MSeif, Larijani B, Iraji A, et al. Design, synthesis, , and evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors. Heliyon. 2023;9(11):e22009.
E
Alizadeh N, Sayahi MHossein, Iraji A, Yazzaf R, Moazzam A, Mobaraki K, Adib M, Attarroshan M, Larijani B, Rastegar H, et al. Evaluating the effects of disubstituted 3-hydroxy-1H-pyrrol-2(5H)-one analog as novel tyrosinase inhibitors. Bioorg Chem. 2022;126:105876.
Ghomi MKhalili, Noori M, Mirahmad M, Iraji A, Sadr AShahir, Dastyafteh N, Asili P, Gholami M, Javanshir S, Lotfi M, et al. Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties. Eur J Med Chem. 2024;269:116332.
N
Dastyafteh N, Noori M, Montazer MNazari, Zomorodian K, Yazdanpanah S, Iraji A, Ghomi MKhalili, Javanshir S, Asadi M, Dianatpour M, et al. New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation. Sci Rep. 2023;13(1):21.
Asadi M, Fayazi F, Iraji A, Sabourian R, Azizian H, Hajimahmoodi M, Larijani B, Mahdavi M, Amanlou M. Nitrophenylpiperazine derivatives as novel tyrosinase inhibitors: design, synthesis, and in silico evaluations. BMC Chem. 2024;18(1):67.
P
Noori M, Dastyafteh N, Safapoor S, Ghomi MKhalili, Tanideh R, Zomorian K, Hamedifar H, Dara M, Zare S, Irajie C, et al. Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3β level targeting Alzheimer's disease. Int J Biol Macromol. 2023:127392.
R
Hajimiri M, Khosravikia M, Khoshneviszadeh M, Pedrood K, Hosseini SZahra, Asgari MSadegh, Pirhadi S, Attarroshan M, Mobaraki K, Hosseini S, et al. Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides as Tyrosinase Inhibitors. Chem Biodivers. 2022:e202100964.
S
Bagheri A, Moradi S, Iraji A, Mahdavi M. Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study. Sci Rep. 2024;14(1):1540.
Rastegari A, Safavi M, Vafadarnejad F, Najafi Z, Hariri R, Bukhari SNasir Abba, Iraji A, Edraki N, Firuzi O, Saeedi M, et al. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease. Mol Divers. 2021.
Hashemi A, Noori M, Dastyafteh N, Sadat-Ebrahimi SEsmaeil, Haghighi NFazelzadeh, Mehrpour K, Sattarinezhad E, Zafrei FJalali, Irajie C, Daneshmehr MAli, et al. Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones. BMC Chem. 2023;17(1):65.
Forozan RD, Ghomi MKhalili, Iraji A, Montazer MNazari, Noori M, Dastyafteh N, Mojtabavi S, Faramarzi MAli, Sadat-Ebrahimi SEsmaeil, Larijani B, et al. Synthesis, in vitro inhibitor screening, structure-activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors. Sci Rep. 2023;13(1):7819.
Shayegan N, Haghipour S, Tanideh N, Moazzam A, Mojtabavi S, Faramarzi MAli, Irajie C, Parizad S, Ansari S, Larijani B, et al. Synthesis, in vitro α-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents. Sci Rep. 2023;13(1):6304.
T
Ghasemi N, Moradi S, Iraji A, Mahdavi M. Thiazolopyrimidine derivatives as novel class of small molecule tyrosinase inhibitor. BMC Chem. 2023;17(1):156.
Noori M, Sabourian R, Tasharoie A, Safavi M, Iraji A, Ghomi MKhalili, Dastyafteh N, Irajie C, Zarenezhad E, Pour SMehrdad Mo, et al. Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-melanogenesis properties. Sci Rep. 2023;13(1):2578.
U
Yousefnejad F, Iraji A, Sabourian R, Moazzam A, Tasharoie S, Mirfazli SSara, Zomorodian K, Akhlagh SAlireza, Hosseini S, Larijani B, et al. Ugi Bis-Amide Derivatives as Tyrosinase Inhibitor; Synthesis, Biology Assessment, and in Silico Analysis. Chem Biodivers. 2022:e202200607.